Clinical trial GO 28509
GO 28509 A phase II, randomized study of paclitaxel with GDC-0941 versus paclitaxel with placebo in patients with locally recurrent or metastatic breast cancer
| Organ | Breast |
|---|---|
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Genentech |
| EudraCT Identifier | 2012-00326-241 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01740336 |
| Inclusion criteria | HER 2-/HR+ |
| Last update |